Ligand validation:3UFV

HW9: 4-methyl-6-{[(3R,4R)-4-{[5-(4-methylpyridin-2-yl)pentyl]oxy}pyrrolidin-3-yl]methyl}pyridin-2-amine

HW9 is a Ligand Of Interest in 3UFV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3UFV_HW9_B_800	17%	35%	0.288	0.871	0.63	1.89	-	6	3	0	100%	1
3UFV_HW9_A_800	10%	32%	0.326	0.837	0.65	2.03	-	8	2	0	100%	1
4CX4_HW9_A_800	32%	31%	0.238	0.913	0.74	1.99	1	10	5	0	100%	0.7481
4CX1_HW9_B_800	97%	28%	0.057	0.969	0.69	2.17	-	10	1	0	100%	1
4CWW_HW9_B_800	95%	33%	0.063	0.967	0.68	1.94	-	9	0	0	100%	1
4CWZ_HW9_B_800	76%	44%	0.102	0.937	0.54	1.6	-	8	4	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.